Navigation Links
febit First to Offer miRBase 11.0 Biochip
Date:4/14/2008

MEDFORD, Mass. and HEIDELBERG, Germany, April 14 /PRNewswire/ -- febit today announced its newest miRNA Biochip based on the new miRBASE version 11.0 which has been released by the Wellcome Trust Sanger Institute yesterday. The new Geniom(R) Biochip opens up the most up-to-date scientific information for miRNA microarray experiments.

febit's flexible Geniom Platform and Services give researchers in the field of genomics access to the latest version of miRBase. The Geniom Biochip can be used as a full service from febit or as a ready-to-go biochip for the new microarray analyzing device from febit, the Geniom RT Analyzer. The Geniom RT Analyzer recently launched in Europe and will be launched in the United States at the RNAi World Congress in Boston (May 1-2, 2008).

About febit

febit enables scientists to read, write and understand the code of life: DNA. With its unique Geniom technology and services, febit is the only company that puts the control of simplified genomic research in the hand of the user. The seamless integration of DNA synthesis and analysis and the superior support in experiment design and bioinformatics helps to understand data and turn it into results. febit's team of experienced scientists is dedicated to support customers to solve the challenge of understanding biological processes. Geniom is a technological and service platform successfully implemented in basic and applied research by renowned institutions and companies. Geniom exploits cutting-edge microarray technology for analysis and synthesis of genes and genomes, providing superior time- and cost-efficiency combined with an unsurpassed spectrum of applications.
http://www.febit.com

Contact:

febit holding gmbh Russo Partners, LLC

Eva Sterzel David Schull or Wendy Lau

Public Relations Manager +1-212-845-4271

+49 (6221) 6510-300 david.schull@russopartnersllc.com

eva.sterzel@febit.de wendy.lau@russopartnersllc.com


'/>"/>
SOURCE febit
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. febit Forms Scientific Advisory Board
2. febit Appoints Michelle Lyles, Ph.D., Vice President, Marketing and Sales
3. ES Vascular Receives CE Mark for its First Aortic Stapler for End-to-End Anastomosis Between Synthetic Grafts and Aorta During Open Repair of Aortic Aneurysmal and Occlusive Disease
4. Dilon Technologies Closes First Quarter With Record Sales
5. First CyberKnife System Sold in Switzerland
6. ARIUS announces first quarter fiscal 2008 financial results
7. Cryo-Cell International, Inc. Reports First Quarter 2008 Results
8. ATS Medical Announces First North American Commercial Implant of the ATS 3f Aortic Bioprosthesis
9. Millennium Announces VELCADE(R) (Bortezomib) for Injection First-Quarter 2008 U.S. Net Sales
10. Leading Geneticist Francis Collins Named First Recipient of the Inamori Ethics Prize at Case Western Reserve University
11. Diffusion Pharmaceuticals Announces Issuance of U.S. Patent No. 7351844, Titled Bipolar Trans Carotenoid Salts and Their Uses, for Its Family of First-In-Class Molecules
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/22/2017)... -- Dublin - Research and ... Protection (Bio-Pesticide) Market-By Type, By Application, By End User, By Region, ... ... Crop Protection Market is forecasted to grow at a CAGR of ... or biological crop protection market is driven by the surging demand ...
(Date:2/22/2017)... DIEGO , Feb. 22, 2017  Creative ... expansion of its translational research program using its ... of laboratory facilities in San Diego.  The Company ... BioLabs facility, a biotechnology incubator sponsored by the ... In November 2016, the Company obtained an ...
(Date:2/21/2017)... ... February 21, 2017 , ... ... System , a fully automated benchtop system for collecting intact circulating tumor cells ... launched at the Molecular Medicine Tri Conference (Tri-Con) Annual Meeting 2017 (February 19–24 ...
(Date:2/21/2017)... ... February 21, 2017 , ... VetStem Biopharma, Inc ... headquarters laboratory in Poway, California. Based upon 12 years of knowledge gained ... and consultants, VetStem constructed and validated a state-of-the-art GMP stem cell manufacturing plant. ...
Breaking Biology Technology:
(Date:1/31/2017)... 2017  Spero Therapeutics, LLC, a biopharmaceutical company ... of bacterial infections, today announced it has acquired ... Pro Bono Bio Ltd (PBB) to bolster its ... forms of Gram-negative bacteria.   The assets acquired have ... PBB group company. "The acquisition of ...
(Date:1/26/2017)... , Jan. 26, 2017  Acuity Market ... for Biometrics and Digital Identity".  Acuity characterizes 2017 ... identity when increased adoption reflects a new understanding ... "Biometrics and digital identity are often ... Maxine Most , Principal of Acuity Market ...
(Date:1/24/2017)... 24, 2017  It sounds simple and harmless—an ... monitors vital signs and alerts parents on their ... saturation level drops. But pediatric experts argue that ... with no evidence of medical benefits, especially to ... aggressively to parents of healthy babies, promising peace ...
Breaking Biology News(10 mins):